Chinese contract research and development services provider WuXi PharmaTech Inc. says it has received a proposal to be taken private by a consortium led by its chief executive Dr. Li Ge and Ally Bridge Group Capital Partners, according to a company announcement. The consortium proposes to acquire all of WuXi PharmaTech's outstanding shares not already […]

Visit for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network